Read/Search this Article
Abstract
A series of fumagillin analogues containing the C6-substituted cinnamoyl moiety were designed, synthesized, and evaluated for antiangiogenic activity. Among them, 4-hydroxyethoxy-cinnamoyl fumagillol (4a) and 4-hydroxyethoxy-3,5-dimethoxycinnamoyl fumagillol (4d) exhibited more potent anti-proliferation activity in CPAE and HUVEC cells with low cytotoxicity in vitro. These compounds are presently under further pharmacological evaluation studies.
Journal
- Chemical & pharmaceutical bulletin [List of Volumes]
-
Chemical & pharmaceutical bulletin 55(7), 1024-1029, 2007-07-01 [Table of Contents]
The Pharmaceutical Society of Japan